StonvexLoading…
StonvexStonvexStonvexCore line items from PZZA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $478.61M | $2.05B | $1.56B | $1.05B |
Operating Income | $20.76M | $89.15M | $64.63M | $48.45M |
Net Income | $7.25M | $30.53M | $23.46M | $18.75M |
EPS (Diluted) | $0.21 | $0.90 | $0.69 | $0.56 |
Total Assets | $831.93M | $837.51M | $884.10M | $890.44M |
Total Liabilities | $1.27B | $1.27B | $1.31B | $1.31B |
Cash & Equivalents | $39.04M | $34.59M | $38.97M | $33.30M |
Free Cash Flow OCF − CapEx | $-6.23M | $61.30M | $59.19M | $36.54M |
Shares Outstanding | 32.90M | 32.80M | 32.80M | 32.80M |